Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus

Contributed equally
Journal of Translational Medicine201816:128

https://doi.org/10.1186/s12967-018-1513-8

  • Received: 30 April 2018
  • Accepted: 8 May 2018
  • Published:

The original article was published in Journal of Translational Medicine 2018 16:109

Correction to: J Transl Med (2018) 16:109 https://doi.org/10.1186/s12967-018-1492-9

Following publication of the original article [1], the authors reported that for one of the authors, Stephanie E. Combs, the middle name was accidentally omitted. They also reported that for two of the authors, Daniel Habermehl and Stephanie E. Combs, two affiliations were accidentally omitted. In this Correction the incorrect and correct author name are shown and the two omitted affiliations are listed.

Originally the author name has been published as:
  • Stephanie Combs

The correct author name is:
  • Stephanie E. Combs

The two missing affiliations for Daniel Habermehl and Stephanie E. Combs are:
  • Department of Radiation Sciences (DRS), Institute of Innovative Radiotherapie (iRT), Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany.

  • Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich Germany.

The complete list of affiliations is included in this Correction.

Notes

Declarations

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Institute of Pathology, Technische Universität München, Trogerstrasse 18, 81675 Munich, Germany
(2)
Department of Surgery, Klinikum Rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675 Munich, Germany
(3)
Department of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675 Munich, Germany
(4)
Department of Radiation Sciences (DRS), Institute of Innovative Radiotherapie (iRT), Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
(5)
Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany
(6)
Teilgemeinschaftspraxis Molekularpathologie Südbayern, Giesinger Bahnhofplatz 2, 81539 Munich, Germany
(7)
Institute of Pathology, University of Bern, Murtenstrasse 31, 3008 Bern, Switzerland

Reference

  1. Slotta-Huspenina J, Drecoll E, Feith M, Habermehl D, Combs SE, Weichert W, Bettstetter M, Becker K. MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus. J Transl Med. 2018;16:109. https://doi.org/10.1186/s12967-018-1492-9.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s) 2018

Advertisement